The induction of high-frequency CD8+ T cell responses is critical to survival in NHP models of EBOV and has also now been demonstrated in human survivors of Ebola virus disease (EVD), suggesting a potential advantage for these vectors (Sullivan et al., 2009, Sakabe et al., 2018). The gene discussed is CD8A; the disease is Ebola hemorrhagic fever.